Trial
NCT04075136
Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy
Phase IVWITHDRAWNSAFETYConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
Modulight
Condition
Exudative Age Related Macular Degeneration
Intervention
Ranibizumab
Why stopped
IRB stopped study due to safety concerns before any participants were enrolled.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-22